Kenya ePrescription FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya ePrescription FHIR Implementation Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Controlled Substance Schedule CodeSystem - XML Representation

Active as of 2026-04-24

Raw xml | Download


<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="controlled-substance-schedule-cs"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem controlled-substance-schedule-cs</b></p><a name="controlled-substance-schedule-cs"> </a><a name="hccontrolled-substance-schedule-cs"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/CodeSystem/controlled-substance-schedule</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">schedule-I<a name="controlled-substance-schedule-cs-schedule-I"> </a></td><td>Schedule I</td><td>Substances with high abuse potential and no accepted medical use (e.g. heroin).</td></tr><tr><td style="white-space:nowrap">schedule-II<a name="controlled-substance-schedule-cs-schedule-II"> </a></td><td>Schedule II</td><td>High abuse potential with severe dependence liability; accepted medical use with restrictions (e.g. morphine, fentanyl).</td></tr><tr><td style="white-space:nowrap">schedule-III<a name="controlled-substance-schedule-cs-schedule-III"> </a></td><td>Schedule III</td><td>Moderate-to-low physical dependence and high psychological dependence potential (e.g. codeine combinations).</td></tr><tr><td style="white-space:nowrap">schedule-IV<a name="controlled-substance-schedule-cs-schedule-IV"> </a></td><td>Schedule IV</td><td>Lower abuse potential relative to schedule III (e.g. benzodiazepines, tramadol).</td></tr></table></div>
  </text>
  <url
       value="https://nshr-uat.sha.go.ke/CodeSystem/controlled-substance-schedule"/>
  <version value="0.1.0"/>
  <name value="ControlledSubstanceScheduleCS"/>
  <title value="Controlled Substance Schedule CodeSystem"/>
  <status value="active"/>
  <date value="2026-04-24T09:57:31+00:00"/>
  <publisher value="DHA, Kenya"/>
  <contact>
    <name value="DHA, Kenya"/>
    <telecom>
      <system value="url"/>
      <value value="https://dha.go.ke/"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="helpdesk@dha.go.ke"/>
    </telecom>
  </contact>
  <contact>
    <name value="Digital Health Agency, Kenya"/>
    <telecom>
      <system value="email"/>
      <value value="helpdesk@dha.go.ke"/>
      <use value="work"/>
    </telecom>
    <telecom>
      <system value="url"/>
      <value value="https://www.dha.go.ke/"/>
    </telecom>
  </contact>
  <description
               value="Schedules for controlled substances under the Kenya Pharmacy and Poisons Act."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="KE"/>
      <display value="Kenya"/>
    </coding>
  </jurisdiction>
  <copyright
             value="Copyright 2025+ Digital Health Agency, Kenya. This content is licensed under Creative Commons Attribution 4.0 International (CC-BY-4.0). Terminology content from the Kenya Pharmacy and Poisons Board (PPB) via Open Concept Lab (OCL) is subject to separate terms."/>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="4"/>
  <concept>
    <code value="schedule-I"/>
    <display value="Schedule I"/>
    <definition
                value="Substances with high abuse potential and no accepted medical use (e.g. heroin)."/>
  </concept>
  <concept>
    <code value="schedule-II"/>
    <display value="Schedule II"/>
    <definition
                value="High abuse potential with severe dependence liability; accepted medical use with restrictions (e.g. morphine, fentanyl)."/>
  </concept>
  <concept>
    <code value="schedule-III"/>
    <display value="Schedule III"/>
    <definition
                value="Moderate-to-low physical dependence and high psychological dependence potential (e.g. codeine combinations)."/>
  </concept>
  <concept>
    <code value="schedule-IV"/>
    <display value="Schedule IV"/>
    <definition
                value="Lower abuse potential relative to schedule III (e.g. benzodiazepines, tramadol)."/>
  </concept>
</CodeSystem>